相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。
Article
Critical Care Medicine
Matan Yechezkel et al.
Summary: This study evaluates the safety profile of the second BNT162b2 mRNA COVID-19 booster vaccine using data from retrospective and prospective cohorts. The results show that the second booster is not associated with any of the investigated adverse events, and there is no significant increase in risk for myocardial infarction and Bell's Palsy. This study provides safety assurances to the global population eligible for an additional COVID-19 booster vaccination.
LANCET RESPIRATORY MEDICINE
(2023)
Article
Geriatrics & Gerontology
Zixin Wang et al.
Summary: This study compared the levels and barriers of physical activity among community-dwelling older adults in Hong Kong during and after the fifth wave of the COVID-19 outbreak. The findings showed that the level of physical activity increased and barriers decreased in the second round of survey. Regular monitoring of physical activity level and associated factors is important for health promotion and policy-making.
Article
Medicine, General & Internal
Nick Andrews et al.
Summary: A study conducted in England showed that vaccines against SARS-CoV-2 provide high protection against hospitalization and death from Covid-19 at 20 weeks or more after vaccination. However, the effectiveness of the vaccines decreases over time, especially in individuals aged 65 and older and those with underlying risk factors.
NEW ENGLAND JOURNAL OF MEDICINE
(2022)
Article
Medicine, General & Internal
Tal Patalon et al.
Summary: This study demonstrated that receiving a booster dose of the BNT162b2 vaccine can reduce the odds of testing positive for SARS-CoV-2 in the short term, potentially counteracting waning immunity. Further monitoring is needed to determine the duration of immunity following the booster dose.
JAMA INTERNAL MEDICINE
(2022)
Article
Immunology
Chenyuan Qin et al.
Summary: Chinese residents showed a high willingness to accept the third dose of COVID-19 vaccines, and acceptance was influenced by previous vaccination history, perceived susceptibility, and action cues.
Editorial Material
Medicine, General & Internal
Halane Vaillant-Roussel et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE
(2022)
Article
Infectious Diseases
Cristina Menni et al.
Summary: This study aimed to investigate the effectiveness and waning of COVID-19 primary vaccine series, as well as the safety and effectiveness of booster doses. The results showed that vaccine effectiveness decreased after the second dose, but booster doses restored effectiveness. However, heterologous booster regimens had more systemic side-effects.
LANCET INFECTIOUS DISEASES
(2022)
Article
Biochemistry & Molecular Biology
Ronen Arbel et al.
Summary: A retrospective analysis of data from Israel shows that a second booster shot of BNT162b2 in individuals aged 60 and over significantly reduces hospitalizations and deaths due to COVID-19.
Article
Medicine, General & Internal
Yinon M. Bar-On et al.
Summary: After administering the fourth dose of BNT162b2 vaccine to individuals aged 60 years and older during the period when the omicron variant was predominant, Israel observed lower rates of confirmed SARS-CoV-2 infection and severe Covid-19 compared to those who received only three doses. The protection against severe illness remained consistent, while the protection against confirmed infection decreased over time.
NEW ENGLAND JOURNAL OF MEDICINE
(2022)
Article
Medicine, General & Internal
Ori Magen et al.
Summary: The use of a fourth dose of BNT162b2 vaccine in Israel starting on January 3, 2022, has shown significant reductions in infection rate, symptomatic infection, hospitalization, and Covid-19-related deaths by February 18.
NEW ENGLAND JOURNAL OF MEDICINE
(2022)
Article
Medicine, General & Internal
Sivan Gazit et al.
Summary: This study examined the effectiveness of a fourth dose of the Pfizer-BioNTech mRNA vaccine compared to three doses over a 10-week period. The results showed that the fourth dose provided additional protection against SARS-CoV-2 infection and severe COVID-19 disease in the first three weeks. However, the relative effectiveness of the fourth dose against infection decreased over time.
BMJ-BRITISH MEDICAL JOURNAL
(2022)
Article
Environmental Sciences
Yudong Miao et al.
Summary: This study aimed to evaluate the psychological experience of COVID-19 basic vaccination and the willingness to receive booster vaccines among Chinese people, and determine their relationships. The survey showed that the majority of participants expressed a willingness to receive booster vaccines. Additionally, individuals with a positive psychological experience were more likely to be willing to receive booster vaccines.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
(2022)
Review
Immunology
Zhaohui Su et al.
Summary: This study conducted a narrative literature review to investigate the factors that shape people's vaccine fatigue. A total of 37 articles were reviewed and analyzed, and a wide range of antecedents to vaccine fatigue were identified, including the frequency of immunization demands, vaccine side effects, misconceptions about disease severity and vaccination, and lack of trust in the government and media. Vaccine fatigue is people's inertia or inaction towards vaccine information or instruction due to perceived burden and burnout. The study suggests that effective and empathetic vaccine communications hold great promise in eliminating preventable vaccine fatigue.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Immunology
Watsamon Jantarabenjakul et al.
Summary: This study assessed the immune response against SARS-CoV-2 after receiving booster shots of BNT162b2 or ChAdOx1 among health care workers who previously received CoronaVac as their primary immunization. The study showed a significant increase in immune response after the booster, including against the Omicron variant. Immune responses decreased at 12 weeks after the booster but were still higher than post-primary vaccination.
Article
Immunology
Zixin Wang et al.
Summary: This study investigated the impacts of incentives and health promotional materials on COVID-19 vaccination completion among older adults in Hong Kong. The findings suggest that most participants did not believe that government incentives or promotional materials had a significant impact on their motivation to get vaccinated. However, participants who perceived higher impacts of incentives and believed in the effectiveness of promotional materials were more likely to complete the vaccination series.
Article
Medicine, General & Internal
Ramandip Grewal et al.
Summary: This study estimated the marginal effectiveness of a fourth dose compared to a third dose of mRNA covid-19 vaccines and the vaccine effectiveness of BNT162b2 and mRNA-1273 vaccines against the omicron variant. The results showed that a fourth dose improved protection against infection, symptomatic infection, and severe outcomes. Vaccine effectiveness increased with each additional dose.
BMJ-BRITISH MEDICAL JOURNAL
(2022)
Article
Public, Environmental & Occupational Health
Ruth Link-Gelles et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
(2022)
Article
Public, Environmental & Occupational Health
Anne M. Hause et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
(2022)
Article
Immunology
Chenyuan Qin et al.
Summary: In China, approximately 17.2% of older adults aged 60 and above expressed hesitancy towards booster doses of COVID-19 vaccines. This hesitation was closely associated with lower levels of perceived susceptibility and benefit, as well as higher levels of perceived barriers. Concerns about contraindications, vaccine safety, and limited movements were the main reasons for the vaccine hesitancy.
Article
Immunology
Zixin Wang et al.
Summary: This study investigated the facilitators and barriers to COVID-19 vaccine booster dose uptake among older adults in Hong Kong. The results showed that positive attitudes, support from significant others, reduced concerns, and helpfulness of governmental promotional materials were associated with higher uptake of the COVID-19 vaccine booster dose among older adults.
Article
Immunology
Xiaofeng Zhou et al.
Summary: This study investigated the changes in parents' COVID-19 vaccine hesitancy for children before and after the vaccination program rollout in China. The prevalence of vaccine hesitancy decreased after the program was implemented. Positive attitudes, subjective norms, and perceived behavioral control were associated with lower vaccine hesitancy.
Review
Medicine, General & Internal
Daniel R. Feikin et al.
Summary: This study systematically reviewed the duration of protection provided by COVID-19 vaccines against various clinical outcomes. The findings indicate that the effectiveness or efficacy of the vaccines decreased from 1 to 6 months after full vaccination, but remained high against severe disease. Evaluating the effectiveness or efficacy of vaccines beyond 6 months is crucial for updating vaccine policies.
Article
Biotechnology & Applied Microbiology
Zixin Wang et al.
Summary: This study investigated factors associated with pneumococcal vaccination (PV) completion among individuals aged 65 years and older in Hong Kong, China. The Health Belief Model constructs, knowledge about pneumococcal diseases and vaccination, and perceived self-efficacy were significantly associated with PV completion. Targeted, theory-based health promotion efforts are needed to increase PV coverage among the elderly in Hong Kong.
HUMAN VACCINES & IMMUNOTHERAPEUTICS
(2021)
Article
Biotechnology & Applied Microbiology
Zixin Wang et al.
Summary: This study found that participants who perceived more severe consequences of pneumonia and believed that treatment can control pneumonia were more likely to receive PV. Meanwhile, perceiving pneumonia to be chronic, belief in treatment control, and negative emotions related to pneumonia were positively associated with the behavioral intention to receive PV.
HUMAN VACCINES & IMMUNOTHERAPEUTICS
(2021)
Article
Medicine, General & Internal
Einav G. Levin et al.
Summary: A study in Israel revealed that waning immunity after receiving two doses of the BNT162b2 vaccine led to an increase in the incidence of SARS-CoV-2 infection. Levels of spike-binding IgG and neutralizing antibodies decreased more significantly in men, individuals aged 65 or older, and immunosuppressed individuals in a longitudinal study involving nearly 4000 healthcare workers.
NEW ENGLAND JOURNAL OF MEDICINE
(2021)
Article
Health Care Sciences & Services
Ke Chun Zhang et al.
Summary: This study investigated the prevalence and factors associated with the intention to receive COVID-19 vaccinations among Chinese factory workers during the pandemic. The results showed that positive attitudes towards vaccination, support from significant others, perceived behavioral control, exposure to positive information through social media, and compliance with preventive measures were all positively associated with the intention to receive a COVID-19 vaccination.
JOURNAL OF MEDICAL INTERNET RESEARCH
(2021)
Article
Immunology
Xiaozhen Lai et al.
Summary: Public acceptance of COVID-19 booster vaccination is relatively high in China, with concerns primarily focused on vaccine safety. Factors influencing acceptance include vaccination history, perceived benefits and barriers, age, education level, employment status, and belonging to priority vaccination groups.
Article
Public, Environmental & Occupational Health
Akansha Singh et al.
Summary: The study found that cultural/religious factors, individual attitudes, exposure to information on social media, and peer influence were determinants of COVID-19 vaccine uptake among South Asians in Hong Kong.
JMIR PUBLIC HEALTH AND SURVEILLANCE
(2021)
Article
Medicine, General & Internal
Jamie Lopez Bernal et al.
Summary: This study estimated the real-world effectiveness of Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S vaccines against confirmed COVID-19 symptoms, hospital admissions, and deaths. The vaccines showed significant reduction in symptomatic COVID-19 among older adults and further protection against severe disease. Both vaccines demonstrated similar effects and protection was maintained for over 6 weeks.
BMJ-BRITISH MEDICAL JOURNAL
(2021)
Article
Infectious Diseases
Clara Mazagatos et al.
Summary: The study found that the effectiveness of mRNA COVID-19 vaccines for elderly residents in long-term care facilities in Spain was estimated at 71%, 88%, and 97% against SARS-CoV-2 infections, COVID-19 hospitalizations, and deaths, respectively.
Article
Infectious Diseases
Catherine Hyams et al.
Summary: The study found that one dose of either the BNT162b2 or ChAdOx1 nCoV-19 vaccines resulted in substantial risk reductions for COVID-19-related hospitalisations in those aged over 80 years.
LANCET INFECTIOUS DISEASES
(2021)
Article
Medicine, General & Internal
Sana Abbas et al.
Summary: This study aimed to determine the immediate side effects of COVID-19 vaccination in the Pakistani population. Results showed that fever, soreness, redness, and swelling at the injection site were the most common side effects, with younger participants more likely to experience gastrointestinal disturbance and flu-like symptoms.
PAKISTAN JOURNAL OF MEDICAL SCIENCES
(2021)
Article
Health Care Sciences & Services
Yihang Pan et al.
JOURNAL OF MEDICAL INTERNET RESEARCH
(2020)
Review
Infectious Diseases
Seung-Ji Kang et al.
INFECTION AND CHEMOTHERAPY
(2020)
